Ignite Creation Date:
2024-05-06 @ 3:52 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04780516
Status:
COMPLETED
Last Update Posted:
2024-01-03
First Post:
2021-03-01
Brief Title:
Study to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Psoriasis Treated With Subcutaneous Risankizumab Injection According to Standard of Care
Sponsor:
AbbVie
Organization:
AbbVie
Organization Data
Organization:
AbbVie
Class:
INDUSTRY
Study ID:
P20-439
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AbbVie
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None